Your session is about to expire
← Back to Search
Cannabinoid
Cannabigerol for Anxiety and Stress
Phase 1
Recruiting
Led By Carrie Cuttler, PhD
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
21+ years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approx. 40 minutes after ingesting cbg/placebo
Awards & highlights
Study Summary
This trial is looking at the effects of a hemp compound, CBG, on anxiety, stress, mood, and cognition. They will also examine any side effects of taking CBG.
Who is the study for?
This trial is for adults over 21 living in Washington state who speak English, can use a computer with a webcam and internet, have used cannabis products safely before, and own a smartphone. Pregnant or breastfeeding individuals, those with recent illicit drug use, serious psychiatric disorders or major medical conditions are excluded.Check my eligibility
What is being tested?
The study tests the effects of hemp-derived cannabigerol (CBG) versus a placebo on anxiety, stress, mood, and cognition. It aims to understand both potential benefits and side effects of CBG on human subjects.See study design
What are the potential side effects?
Possible side effects from CBG may include sleepiness, dry mouth and eyes, as well as an increased appetite. The severity of these side effects will be closely monitored throughout the study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 21 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approx. 40 minutes after ingesting cbg/placebo
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approx. 40 minutes after ingesting cbg/placebo
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Anxiety
Change in Mood
Change in Stress
Secondary outcome measures
Change in Potential Side Effects (dry mouth, dry eyes, sleepiness, increased appetite, intoxication, heart palpitations/racing heart)
Memory
Psychomotor
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: CBGExperimental Treatment1 Intervention
Participants will ingest 20 mg of CBG tincture in this arm
Group II: PlaceboPlacebo Group1 Intervention
Participants will ingest 20 mg of placebo tincture in this arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabigerol
Not yet FDA approved
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Washington State UniversityLead Sponsor
101 Previous Clinical Trials
56,680 Total Patients Enrolled
Carrie Cuttler, PhDPrincipal InvestigatorWashington State University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must be able to read and write.You are able to speak English fluently.You are pregnant or currently breastfeeding.I am over 21 years old.I have used cannabis products before without any severe side effects.I do not have serious neurological conditions or head injuries.You have used illegal drugs in the last 2 months.You have a smartphone.You have been diagnosed with severe mental health conditions such as psychotic or bipolar disorder.
Research Study Groups:
This trial has the following groups:- Group 1: CBG
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals are currently participating in this research trial?
"Affirmative. Clinicaltrials.gov verifies that this clinical trial is currently recruiting participants; the initial posting was on March 24th 2022 and the final update was on August 11th 2022. A total of 34 individuals from a single site are needed."
Answered by AI
Are there any open vacancies for participants in this trial?
"Affirmative. According to the details on clinicaltrials.gov, this research endeavor was initially declared on March 24th 2022 and is still actively enrolling patients. 34 individuals from 1 centre are needed for the trial's completion."
Answered by AI
Has the Cannabigerol drug been validated by the Food and Drug Administration?
"Our assessment of Cannabigerol's safety is rated 1 due to the limited data available from Phase 1 trials, meaning there are no conclusive results on efficacy or safety."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger